Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Bull Exp Biol Med ; 156(6): 736-9, 2014 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-24824683

RESUMO

Patterns of expression of TRPM7, the major cellular magnesium transporters in neurons of the hypothalamic region and hippocampus, were studied immunohistochemically. Multidirectional nature and different levels of the expression of the above antigen were revealed during modeled magnesium deficiency with regard to structural and functional features of neuron organization in the hypothalamic paraventricular and supraoptic nuclei as well as hippocampal field CA1 and CA3. Changes in the structural characteristics of neurons in the studied areas (absolute and relative indicators) and TRPM7 expression patterns were quantitatively analyzed considering the data on the role of the studied antigen in magnesium homeostasis, cell damage, and compensation.


Assuntos
Hipocampo/metabolismo , Hipotálamo/metabolismo , Deficiência de Magnésio/metabolismo , Neurônios/metabolismo , Canais de Cátion TRPM/biossíntese , Animais , Região CA1 Hipocampal/citologia , Região CA1 Hipocampal/metabolismo , Região CA3 Hipocampal/citologia , Região CA3 Hipocampal/metabolismo , Transporte de Íons , Magnésio , Masculino , Núcleo Hipotalâmico Paraventricular/citologia , Núcleo Hipotalâmico Paraventricular/metabolismo , Ratos , Núcleo Supraóptico/citologia , Núcleo Supraóptico/metabolismo
2.
Morfologiia ; 133(1): 60-4, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19069418

RESUMO

The structural alterations in pancreatic islets in streptozotocin-induced diabetic rats were studied after the administration of Gymnema sylvestre extract or its composition. Diabetes mellitus was modeled by daily injection of streptozotocin (20 mg/kg for 5 days) and single injection of 0.2 ml of complete Freund's adjuvant, Only the animals with the blood glucose level exceeding 15 mmol/l were included in the experiment. B- and A-endocrinocytes were demonstrated using immunocytochemistry. The proportions of the area of the pancreatic islets, occupied by B- and A-endocrinocytes, as well as the volume fraction of the pancreatic islets within the pancreas, were determined. In the model of streptozotocin-induced diabetes, the part of the total islet area occupied by B-endocrinocytes, was diminished in the pancreatic islets located in all the zones of the gland. Prophylactic administration of Gymnema sylvestre extract or its composition tended to restore the area occupied by B-endocrinocytes in the pancreatic islets. These results indicate the equal potency of the composition and extract of Gymnema sylvestre to induce the regeneration of B-endocrinocytes.


Assuntos
Diabetes Mellitus Experimental/patologia , Suplementos Nutricionais , Gymnema sylvestre/química , Hipoglicemiantes/uso terapêutico , Ilhotas Pancreáticas/efeitos dos fármacos , Ilhotas Pancreáticas/patologia , Animais , Glicemia/análise , Diabetes Mellitus Experimental/tratamento farmacológico , Hipoglicemiantes/administração & dosagem , Hipoglicemiantes/farmacologia , Imuno-Histoquímica , Masculino , Extratos Vegetais/administração & dosagem , Extratos Vegetais/farmacologia , Extratos Vegetais/uso terapêutico , Ratos , Estreptozocina
3.
Vopr Pitan ; 77(6): 62-71, 2008.
Artigo em Russo | MEDLINE | ID: mdl-19227867

RESUMO

Aims of our work were to appraise the quantity and nature of renal calcifications and mineral metabolism in the magnesium-deficient rats; and to find out whether the combination of pyridoxine with Mg L-aspartate or Mg chloride will reduce the length of the treatment needed to recover rats from magnesium deficient condition and urolithiasis state. To induce hypomagnesemia, fifty rats were placed on a magnesium-deficient diet (magnesium content < or = 15 mg/kg) and demineralized water for 10 weeks. On the forty-ninth day of magnesium-deficient diet, rats were treated one of the six supplementations: MgCl2, Mg-L-Asp or their combinations with pyridoxine hydrochloride, magnesium sulfate, magne B6.


Assuntos
Compostos de Magnésio/uso terapêutico , Deficiência de Magnésio/complicações , Nefrolitíase/tratamento farmacológico , Nefrolitíase/etiologia , Animais , Ácido Aspártico/administração & dosagem , Ácido Aspártico/uso terapêutico , Modelos Animais de Doenças , Ácido Láctico/administração & dosagem , Ácido Láctico/uso terapêutico , Compostos de Magnésio/administração & dosagem , Deficiência de Magnésio/sangue , Deficiência de Magnésio/tratamento farmacológico , Masculino , Nefrolitíase/sangue , Ratos , Resultado do Tratamento , Vitamina B 6/administração & dosagem , Vitamina B 6/uso terapêutico
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA